SCHEMBL2463424

SCHEMBL2463424

Fc1c(Br)ccc2nc(Cl)n3ncnc3c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2463455 0.83 MBOAT4 (0.34)
SCHEMBL12225088 0.83 PDE1B (0.34)
SCHEMBL2533033 0.75 SOS1 (0.35)
Hydrochloric Acid SCHEMBL2466905 0.74 SOS1 (0.35)
SCHEMBL7395649 0.73 ADORA3 (0.39)
SCHEMBL2468305 0.71 TSHR (0.33)
SCHEMBL12225101 0.71 HRH4 (0.33)
SCHEMBL12225113 0.71 HTT (0.43)
SCHEMBL31167564 0.68 CHEK1 (0.37)
SCHEMBL2467047 0.68 CHEK1 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110257137-A1 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2011-10-20 US disclosed
US-20110257137-A1 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2011-10-20 US disclosed
US-20110257137-A1 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2011-10-20 US disclosed
WO-2011112731-A2 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2011-09-15 WO disclosed